Form 4 for ULBI ULTRALIFE CORP
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0001437749-23-004336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-23 | 2023-02-21 | ULBI | Manna Michael Edward | Pres, CEO, Dir | A - Grant | $4.07 | +12.5K | 8,000 | New | +$50.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ISO Stock Options for ULBI Common Stock; $.10 par value (1) | 2023-02-21 | A | A | 12,500 | $4.07 | 8,000 | D | — | — | (F1) On February 21, 2023 Ultralife Corporation's Board of Directors awarded 12,500 stock options to Michael E. Manna under Ultralife's 2014 Long-Term Incentive Plan as Amended. These options vest as follows: 4,167 options vest on February 21, 2024; 4,167 options vest on February 21, 2025 and 4,166 options vest on February 21, 2026. The price reported is the volume weighted average price (VWAP) for Ultralife Common Stock on February 21, 2023, the date of award. |